Welcome to the e-CCO Library!

DOP19: Incidence and initial disease presentation of inflammatory bowel diseases in Denmark: findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Attauabi, M.(1,2)*;Madsen, G.R.(2,3);Wewer, A.V.(2,4);Bendtsen, F.(2,3);Jakobsen, C.(2,4);Dorn-Rasmussen, M.(2,4);Malham, M.(2,4);Theede, K.(2,3);Bjerrum, J.T.(1);Boysen, T.(2,3);Seidelin, J.B.(1);Burisch, J.(2,3);
Created: Friday, 14 July 2023, 10:43 AM
DOP19: Myeloid and lymphoid cell abnormalities persist in the intestinal mucosa of patients who recover from COVID-19 infection
Year: 2022
Source: ECCO'22
Authors: Meringer, H.(1);Tokuyama, M.(1);Tankelevich, M.(1);Martinez-Delgado, G.(1);Jha, D.(1); Livanos, A.E.(1);Canales-Herrerias, P.(1);Cossarini, F.(2);Mehandru , S.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
Year: 2020
Source: ECCO'20 Vienna
Authors: Jason Rogers
Created: Tuesday, 23 June 2020, 5:40 PM
DOP19: Real-world healthcare resource utilisation among patients with Inflammatory Bowel Disease administered vedolizumab for 6 months
Year: 2020
Source: ECCO'20 Vienna
Authors: Jason Rogers
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP19: Spermidine treatment ameliorates experimental colitis in vivo
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Niechcial*1, E. Katkeviciute1, L. Hering1, M. Wawrzyniak1, M. Schwarzfischer1, K. Bäbler1, K. Attrot1, M. Scharl1,2, M. R. Spalinger1

Created: Friday, 22 February 2019, 9:41 AM
DOP19: Urinary metabolome in newly diagnosed treatment-naïve Crohn’s Disease patients: Results from the IBDomics study
Year: 2021
Source: ECCO'21 Virtual
Authors: Aldars-García, L.(1);Gil-Redondo, R.(2);Embade, N.(2);Riestra, S.(3);Rivero, M.(4);Gutiérrez, A.(5);Rodríguez, I.(6);Fernández, L.(7);Ceballos, D.(8);Benítez, J.M.(9);Aguas, M.(10);Bastón-Rey, I.(11);Algaba, A.(12);Casanova, M.J.(1);Lorente, R.(13);Ber, Y.(14);Royo, V.(15);Esteve, M.(16);Millet, O.(2);Gisbert, J.P.(1);Chaparro, M.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
DOP20 Can lifestyle and psychosocial factors predict flares of IBD; an exploratory study using telemedicine
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R.C.A. Lalisang1, G. Adriaans2, M. de Jong3, A. van der Meulen-de Jong4, M. Romberg-Camps5, N. Mahmmod6, T. Markus-de Kwaadsteniet7, G. Dijkstra8, J. Haans2, C. Stamm9, R. Vanwersch10, D. Jonkers11, R.J. Almeida12,13, M.J. Pierik2, MyIBDcoach Study Group

Created: Thursday, 30 January 2020, 10:12 AM
DOP20: Can lifestyle and psychosocial factors predict flares of IBD; an exploratory study using telemedicine
Year: 2020
Source: ECCO'20 Vienna
Authors: Greetje Adriaans
Created: Tuesday, 23 June 2020, 5:40 PM
DOP20: Can lifestyle and psychosocial factors predict flares of IBD; an exploratory study using telemedicine
Year: 2020
Source: ECCO'20 Vienna
Authors: Greetje Adriaans
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP20: Changes in systemic antibody epitope repertoires from preclinical to established Inflammatory Bowel Disease
Year: 2024
Source: ECCO'24 Stockholm
Authors: Bourgonje, Arno R.
Created: Tuesday, 30 April 2024, 5:03 PM
DOP20: Drugs that modulate histone acetylation disrupt TGF-β-signalling and reduce collagen I expression in models of stricturing Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Lewis*1, A. Nijhuis1, G. Berti1, C. Felice2, R. Jeffrey1, S. Iqbal1, A. B. Pomeranc1, S. Aldelemi1, S. Mehta1, E. Giannoulatou3, R. Feakins4, A. Armuzzi2, J. O. Lindsay5, A. Silver1

Created: Friday, 22 February 2019, 9:41 AM
DOP20: Drugs that modulate histone acetylation disrupt TGF-β- signalling and reduce collagen I expression in models of stricturing Crohn’s disease
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Amy Lewis
Created: Tuesday, 28 May 2019, 3:32 PM
Files: 1
DOP20: Functional viral neutralisation responses after SARS-CoV-2 infection in Inflammatory Bowel Disease patients receiving infusion therapies: Report from the ICARUS-IBD Consortium
Year: 2022
Source: ECCO'22
Authors: Wellens, J.(1,2);Edmans, M.(3);Obolski, U.(4,5);Marlow, L.(1);Brann, S.(1);Dunachie, S.(3,6,7);Eyre, D.(8,9);Helmus, D.(10);Barnes, E.(1,3);Colombel, J.F.(10);Wong, S.Y.(10);Klenerman, P.(1,3);Lindsay, J.O.(11,12);Thompson, C.P.(13);Satsangi, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP20: Genetic of vitamin D as predictor of response to adalimumab in Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Cusato, J.(1);Ribaldone, D.G.(1);Bertani, L.(2);Antonucci, M.(1);Tomasello, C.(3);Caviglia, G.P.(1);Dibetto, S.(1);Mangia, M.(1);Astegiano, M.(4);D'Avolio, A.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP20: The impact of early life antibiotics on the occurrence of paediatric inflammatory bowel disease - a nationwide study from 1995 – 2018
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mikkel Malham
Created: Friday, 14 July 2023, 2:22 PM
DOP20: The impact of early life antibiotics on the occurrence of paediatric inflammatory bowel disease - a nationwide study from 1995 – 2018
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jawad, A.(1);Jansson, S.(1,2);Malham, M.(1,2)*;Wewer, V.(1,2);
Created: Friday, 14 July 2023, 10:43 AM
DOP21 Time to first treatment with biologic agents for ulcerative colitis and Crohn’s disease across four Nordic countries: Results from the TRINordic study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Høivik1, M. Lördal2, J. Burisch3, E. Langholz4, T. Knudsen5, M. Voutilainen6, B. Moum1, K. Anisdahl1, B. Saebo7, P. Haiko8, C. Malmgren9, M. Coskun10, H.O. Melberg11

Created: Thursday, 30 January 2020, 10:12 AM
DOP21: Disease activity patterns of paediatric Inflammatory Bowel Disease – A Danish nationwide cohort study 1996-2018
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mads Damsgaard Wewer
Created: Friday, 14 July 2023, 2:22 PM
DOP21: Disease activity patterns of paediatric Inflammatory Bowel Disease – A Danish nationwide cohort study 1996-2018
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wewer, M.D.(1,2,3)*;Jansson, S.(3,4,5);Malham, M.(3,4,6);Burisch, J.(1,3);Wewer, V.(3,4,7);
Created: Friday, 14 July 2023, 10:43 AM
DOP21: Histo-endoscopic remission (HEMR) Predicts Future Relapse in Patients with Ulcerative Colitis and is Associated with Lower Colectomy Risk
Year: 2024
Source: ECCO'24 Stockholm
Authors: Lenfant, Matthias
Created: Tuesday, 30 April 2024, 5:03 PM